{"id":54573,"date":"2023-03-07T13:06:34","date_gmt":"2023-03-07T12:06:34","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/"},"modified":"2023-03-07T13:06:34","modified_gmt":"2023-03-07T12:06:34","slug":"flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/","title":{"rendered":"Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That Are Programed to Act Only Where Needed"},"content":{"rendered":"
\n

\nThe Company’s Proprietary Address, Navigate, Design (AND)\u2122 Platform Produces Medicines that are Better, Safer and More Tolerable for Patients<\/i>\n<\/p>\n

\nAfter Two Years of Development, Flagship Commits $50 Million to Advance the Company’s Platform and Build an Initial Pipeline of Therapeutics<\/i>\n<\/p>\n

CAMBRIDGE, Mass.–(BUSINESS WIRE)–#biotech<\/a>–Flagship Pioneering, the bioplatform innovation company, today unveiled Ampersand Biomedicines, a company creating programmable medicines that are safer, more tolerable, and effective by acting at the site of disease. Flagship has initially committed $50 million to advance the company\u2019s Address, Navigate, Design (AND)\u2122 Platform and develop an initial pipeline of medicines across a range of disease areas.\n<\/p>\n

<\/a><\/p>\n

\n\u201cMost existing medicines affect cells not just at the site of disease but throughout the body. In some cases, this is a benefit, but in many instances, it creates a significant burden of \u2018off tissue\u2019 toxicity and safety concerns that can impede the utility of a drug,\u201d said Noubar Afeyan, Ph.D., Co-Founder and Chairman of Ampersand and Founder and CEO, Flagship Pioneering. \u201cThis led us to ask, what if we could direct medicines in a programmable and precise way to act conditionally at the site of disease? By decoupling the burden of specificity from the needed biological effect, Ampersand has unlocked a new targeting axis for precisely localizing medicines, paving the way for potentially safer, more effective therapies across a wide range of diseases.\u201d\n<\/p>\n

\nAmpersand is using its computationally powered AND-Platform to create next-generation modular medicines designed to effectively target the site of disease without affecting healthy tissue or cells. The Platform\u2019s proprietary, first-of-its-kind Address Map is based on a comprehensive multi-omics characterization of human biology, spanning healthy and diseased states, and enables the identification of the ideal localizers for any organ, cell, and disease. Using these technologies and insights, Ampersand is able to create novel programmable medicines \u2013 called AND-Body\u2122 Therapeutics \u2013 which localize to their intended target and conditionally actuate biology to treat disease, enabling improved target engagement while limiting on-target, off-tissue side effects.\n<\/p>\n

\n\u201cAmpersand is using powerful computational tools, combined with our integrated screening capabilities, to engineer and optimize medicines across both physical and biological constraints, to produce therapies that act as intended, conditionally at the site of disease,\u201d said Avak Kahvejian Ph.D., Co-Founder and CEO of Ampersand and Flagship Pioneering General Partner. \u201cThe versatility of the AND-Platform allows us to aim at a broad range of diseases simultaneously for maximum patient benefit.\u201d\n<\/p>\n

\nIn addition to Noubar Afeyan and Avak Kahvejian, Ampersand\u2019s founding team includes Flagship\u2019s Yann Echelard, Ph.D., President, Raffi Afeyan, Ph.D., Head of Innovation, Charlotte Nicod, Ph.D., and Nick Plugis, Ph.D.\n<\/p>\n

\nAbout Ampersand Biomedicines
\n
<\/b>Ampersand Biomedicines enables a new way of designing programmable medicines that work precisely where needed in the body and nowhere else. The company\u2019s state-of-the-art computationally powered Address, Navigate, Design (AND)\u2122 Platform continually learns the rules for identifying optimal localizer targets and refines its ability to design across the complex space of localizers and actuators. The result is increasingly sophisticated AND-Body\u2122 therapeutics that are engineered across the physical constraints of molecules and the biological characteristics of the targets to effectively target the site of disease without affecting healthy tissue or cells. Ampersand Biomedicines was founded in 2020 at Flagship Labs, a unit of Flagship Pioneering. For more information, please visit www.ampersand.bio<\/a>.\n<\/p>\n

\nAbout Flagship Pioneering
\n
<\/b>Flagship Pioneering conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability. Since its launch in 2000, the firm has, through its Flagship Labs unit, applied its unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in more than $100 billion in aggregate value. To date, Flagship has deployed over $3.1 billion in capital toward the founding and growth of its pioneering companies alongside more than $19 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 42 transformative companies, including Denali Therapeutics (NASDAQ: DNLI<\/a>), Evelo Biosciences (NASDAQ: EVLO<\/a>), Foghorn Therapeutics (NASDAQ: FHTX<\/a>), Indigo Ag, Moderna (NASDAQ: MRNA<\/a>), Omega Therapeutics (NASDAQ: OMGA<\/a>), Sana Biotechnology (NASDAQ: SANA<\/a>), and Seres Therapeutics (NASDAQ: MCRB<\/a>).\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/b>
press@flagshippioneering.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The Company’s Proprietary Address, Navigate, Design (AND)\u2122 Platform Produces Medicines that are Better, Safer and More Tolerable for Patients After Two Years of Development, Flagship Commits $50 Million to Advance the Company’s Platform and Build an Initial Pipeline of Therapeutics CAMBRIDGE, Mass.–(BUSINESS WIRE)–#biotech–Flagship Pioneering, the bioplatform innovation company, today unveiled Ampersand Biomedicines, a company creating … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54573","6":"format-standard","7":"category-industry"},"yoast_head":"\nFlagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That Are Programed to Act Only Where Needed - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That Are Programed to Act Only Where Needed - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The Company’s Proprietary Address, Navigate, Design (AND)\u2122 Platform Produces Medicines that are Better, Safer and More Tolerable for Patients After Two Years of Development, Flagship Commits $50 Million to Advance the Company’s Platform and Build an Initial Pipeline of Therapeutics CAMBRIDGE, Mass.–(BUSINESS WIRE)–#biotech–Flagship Pioneering, the bioplatform innovation company, today unveiled Ampersand Biomedicines, a company creating ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-07T12:06:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230307005245\/en\/1731028\/21\/Ampersand-logo-color-small.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That Are Programed to Act Only Where Needed\",\"datePublished\":\"2023-03-07T12:06:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\\\/\"},\"wordCount\":694,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005245\\\/en\\\/1731028\\\/21\\\/Ampersand-logo-color-small.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\\\/\",\"name\":\"Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That Are Programed to Act Only Where Needed - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005245\\\/en\\\/1731028\\\/21\\\/Ampersand-logo-color-small.jpg\",\"datePublished\":\"2023-03-07T12:06:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005245\\\/en\\\/1731028\\\/21\\\/Ampersand-logo-color-small.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005245\\\/en\\\/1731028\\\/21\\\/Ampersand-logo-color-small.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That Are Programed to Act Only Where Needed\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That Are Programed to Act Only Where Needed - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/","og_locale":"en_US","og_type":"article","og_title":"Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That Are Programed to Act Only Where Needed - Pharma Trend","og_description":"The Company’s Proprietary Address, Navigate, Design (AND)\u2122 Platform Produces Medicines that are Better, Safer and More Tolerable for Patients After Two Years of Development, Flagship Commits $50 Million to Advance the Company’s Platform and Build an Initial Pipeline of Therapeutics CAMBRIDGE, Mass.–(BUSINESS WIRE)–#biotech–Flagship Pioneering, the bioplatform innovation company, today unveiled Ampersand Biomedicines, a company creating ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-07T12:06:34+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230307005245\/en\/1731028\/21\/Ampersand-logo-color-small.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That Are Programed to Act Only Where Needed","datePublished":"2023-03-07T12:06:34+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/"},"wordCount":694,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230307005245\/en\/1731028\/21\/Ampersand-logo-color-small.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/","url":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/","name":"Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That Are Programed to Act Only Where Needed - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230307005245\/en\/1731028\/21\/Ampersand-logo-color-small.jpg","datePublished":"2023-03-07T12:06:34+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230307005245\/en\/1731028\/21\/Ampersand-logo-color-small.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230307005245\/en\/1731028\/21\/Ampersand-logo-color-small.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/flagship-pioneering-unveils-ampersand-biomedicines-to-create-highly-effective-medicines-that-are-programed-to-act-only-where-needed\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That Are Programed to Act Only Where Needed"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54573","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54573"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54573\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54573"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54573"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}